Showing results (51-60 of 281) with videos related to

Sort By:
Pageof 29
The Western Journal of Emergency Medicine|September 7, 2017
Predictors of Return Visits Among Insured Emergency Department Mental Health and Substance Abuse Patients, 2005-2013Sangil Lee, Jeph Herrin, William V Bobo, et al.
Journal of the American Geriatrics Society|October 12, 2019
Home Health Care After Skilled Nursing Facility Discharge Following Heart Failure HospitalizationHimali Weerahandi, Haikun Bao, Jeph Herrin, et al.
JACC. Heart Failure|December 15, 2015
Do Non-Clinical Factors Improve Prediction of Readmission Risk?: Results From the Tele-HF StudyHarlan M Krumholz, Sarwat I Chaudhry, John A Spertus, et al.
JAMA Health Forum|October 28, 2022
Trends in Racial and Ethnic Disparities in Barriers to Timely Medical Care Among Adults in the US, 1999 to 2018César Caraballo, Chima D Ndumele, Brita Roy, et al.
Circulation|February 9, 2005
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysisBrahmajee K Nallamothu, Eric R Bates, Jeph Herrin, et al.
BMJ Medicine|August 14, 2023
Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trialYihong Deng, Eric C Polley, Joshua D Wallach, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Medicare Payment for Calcium Modification Technologies Among Patients Undergoing Percutaneous Coronary Intervention, 2021-2022Jamie Schlacter, Huihui Yu, Sarah Tsuruo, et al.
Archives of Internal Medicine|July 27, 2011
Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controlsBrett D Stauffer, Cliff Fullerton, Neil Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicityJames B Yu, Laura D Cramer, Jeph Herrin, et al.
Ophthalmology|August 12, 2020
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical PracticeMaya H Maloney, Stephanie R Payne, Jeph Herrin, et al.
Pageof 29